Oslo, February 23[rd], 2020 – Observe Medical ASA (OSE: OBSRV) today released its presentation of the fourth quarter 2020, reporting continued progress in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “Sippi® contributes to improved clinical outcome…
Oslo February 22, 2021 – Observe Medical ASA (OSE: OBSERV), announces that Nya Karolinska Sjukhuset in Stockholm, Sweden resumes the implementation of Sippi® in clinical use at the Cardiothoracic ICU unit following a pause during 2020, due to Covid-19 As a result of the recent improvements of the Covid-19 situation at the hospital, the…
Observe Medical ASA invites you to a presentation of the fourth quarter 2020 on Tuesday February 23 at 8.30 CET. Due to the covid-19 situation the presentation will only be held as a webcast. The event will start at 08.30 CET and will be webcasted on www.observemedical.com – Investor relations and on the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210223_2/…
Oslo February 12, 2021 – Observe Medical ASA (OSE: OBSERV), announces that a major hospital in Northern Italy has equipped the ICU department with Sippi® systems in clinical use, the result of the close collaboration with Observe Medical distributor in Italy, SIM Italia. As a result of the strengthened partnership in 2020 with the distributor…
Oslo February 4, 2021 – Observe Medical ASA (OSE: OBSERV), announces strengthened presence in Norway through a partnership agreement with the Norwegian medtech agency Yallow Life Science AS and an enhanced collaboration with Norway Health Tech. Observe Medical, with headquarters in Oslo, Norway, is launching Sippi® automated digital urine meter in selected markets in Europe.…
Oslo 29 January 2021 – Observe Medical ASA (OSE: OBSERV), today announces that Observe Medical Group has received a significant order for medical consumables from a hospital region in the Nordic market. Following the recent acquisition and integration of Sylak AB, Observe Medical has delivered strong sales performance and today announces a significant order for…
Observe Medical ASA, January 15, 2021 – A doctoral (PhD) dissertation at Karolinska Institute, Stockholm, Sweden, demonstrates multiple clinical benefits of the Sippi® automated digital urine meter, and the potential paradigm shift in clinical practice of urine measurement. The PhD thesis ‘Evaluation of an automatic urinometer including use of silicone oil to decrease biofilm formation…
Observe Medical ASA, December 21, 2020: Following the acquisition by Observe Medical of Sylak AB on October 30, the team and product portfolio are now successfully integrated into Observe Medical and in full operations, with focus on the Swedish market. Observe Medical is currently launching Sippi® automated digital urine meter in selected markets in Europe,…
Oslo, November 3rd, 2020 – Observe Medical ASA (OSE: OBSERV) today released its presentation of the third quarter 2020, reporting important steps forward in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “With Sippi®, Observe Medical contributes…
Observe Medical ASA invites you to a presentation of the third quarter 2020. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, November 3. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and on the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201103_4 Due to COVID-19 and corresponding…
Observe Medical ASA, October 30, 2020: On October 29, 2020, Observe Medical announced the signing of the final agreement to acquire Sylak AB, a distributor of ICU/anaesthesia products in the Swedish market, for an enterprise value of SEK 6 million (on a cash and debt free basis). All conditions in the agreement is met, and…
Observe Medical ASA, October 29, 2020: Reference is made to Observe Medical’s announcement October 16, 2020 regarding the signing of a letter of intent to acquire Sylak AB, a distributor of ICU/anaesthesia products in the Swedish market, for an enterprise value of SEK 6 million (on a cash and debt free basis). Today, Observe Medical…
Observe Medical ASA, October 16, 2020: Observe Medical ASA (the "Company" or "Observe Medical") has signed a non-binding term sheet including an exclusive right to acquire 100% of the shares in Sylak AB (“Sylak”), a Swedish private limited company, for an agreed enterprise value of SEK 6 million (on a cash and debt free basis)…
Oslo, 4 September 2020: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 31 August 2020 regarding the exercise of employee share options and issue of 171,875 new shares in the Company. The NOK 44,687.50 share capital increase pertaining to the exercise of the employee share options has now…
Oslo, 31 August 2020: The board of directors of Observe Medical ASA (the "Company") has resolved to increase the share capital of the Company following the completion of an exercise period for vested share options. 1. Exercise of employee share options In total 171,875 employee share options were exercised, giving the option holders the right…
Oslo, 18 August 2020 – Observe Medical ASA (OSE: OBSERV) today released its interim report for the second quarter and first half year of 2020. The company’s initial product, Sippi, a unique and proprietary solution for digital automated urine monitoring in hospitals is in an early stage of commercialization. The company confirms its market estimate…
A recently published article demonstrates that the patented Sippcoat® technology, an integrated part of Sippi® system, from Observe Medical, significantly reduces microbial biofilm formation in medical devices, suggesting a new strategy for reducing hospital-acquired infections. The article “Making medical devices safer: impact of plastic and silicone oil on microbial biofilm formation” was recently published in…
Observe Medical ASA invites you to a presentation of the second quarter and first half year of 2020 figures. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, August 18th. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link:…
Oslo 7 August 2020 – Observe Medical ASA (OSE: OBSERV), today announces it has entered into an updated distribution agreement and strengthened partnership with SIM Italia S.r.l. for the launch of Sippi® in the Italian market. “We are pleased to announce our strengthened partnership with SIM Italia and the signing of an updated distribution agreement…
(Oslo, 20 July 2020) Notice of exercise of employee share options In connection with the expiry date at 31 March 2020, postponed by the Board of Directors to no later than 30 September 2020, Kathrine Gamborg Andreassen, board member, have at 20 July 2020 given notice that she will exercise a total of 125,000 options…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Reference is made to Observe Medical ASA's (the "Company") stock exchange announcement on 6 July 2020 regarding the final result in the in the rights issue of 4,090,909 new shares in the Company (the "Offer Shares") at a subscription price of NOK 11.00 per share (the "Rights Issue"). Navamedic ASA ("NAVA"), represented at the Company's…
Reference is made to Observe Medical ASA's (the "Company") stock exchange announcement on 6 July 2020 regarding the final result in the in the rights issue of 4,090,909 new shares in the Company (the "Offer Shares") at a subscription price of NOK 11.00 per share (the "Rights Issue"). Ingerø Reiten Investment Company AS ("IRIC"), represented…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Oslo, Norway, 3 July 2020. Primary Insider and CEO, Björn Larsson, has today purchased 17,000 shares in Observe Medical ASA at an average price of NOK 13.27. Following this transaction, Björn Larsson holds 17,000 shares and 120,000 options in Observe Medical ASA. Primary insider and CFO, Per Arne Nygård, has today purchased 18,921 shares in…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Reference is made to the ongoing rights issue of 4,090,909 new shares (the "Offer Shares") at a subscription price of NOK 11.00 per share in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue"). Primary insider, Kathrine Gamborg Andreassen, a member of the Company's…
Observe Medical ASA has today, June 30, 2020, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. Björn Larsson, CEO, Observe Medical ASA Tel.: + 46 76 620 17 25…
Reference is made to the ongoing rights issue of 4,090,909 new shares to a subscription price of NOK 11.00 (the "Offer Shares") in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue").Ingerø Reiten Investment Company AS ("IRIC"), represented at the Company's board of directors…
Reference is made to the ongoing rights issue of 4,090,909 new shares to a subscription price of NOK 11.00 (the "Offer Shares") in Observe Medical ASA (the "Company") as announced in the Company's stock exchange announcement on 19 June 2020 (the "Rights Issue"). Navamedic ASA ("NAVA"), represented at the Company's board of directors by Kathrine…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
The annual general meeting of Observe Medical ASA (OSE: OBSERV) will be held on Tuesday, June 30 2020 at 14:00 (CET) in the Observe Medical offices in Henrik Ibsens gate 90 (3rd floor), 0255 Oslo. The Notice of the Annual General Meeting is attached. Due to the restrictions caused by Covid-19 and advice from the…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Oslo, 12 May 2020 – Observe Medical ASA (OSE: OBSERV) today released its presentation of the first quarter 2020, including an updated market study indicating a doubling of the potential market value for the company’s first product, Sippi®. The company’s long term revenue ambition for Sippi® is increased accordingly to NOK 500 million. “During the…
Observe Medical ASA invites you to a presentation of the first quarter 2020 figures. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, May 12th. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link: https://channel.royalcast.com/webcast/hegnarmedia/20200512_4/ Representatives from the Company…
Attached Observe Medical ASA`s annual report for 2019. The report is also available on the company's website, www.observemedical.com The annual report was reviewed and approved by the board of directors on 29 April 2020. The final financial statements included in the annual report has no significant changes since the preliminary results for the full year…
Oslo, 19 March 2020 – Observe Medical ASA (OSE: OBSERV) today provides a business update in light of COVID-19. The company reports continued high activity level in operations, and several initiatives in the launch and roll-out of Sippi®. “The evolving COVID-19 situation has serious impact on all aspects of the global society, specifically the healthcare…
Observe Medical ASA, 28 February 2020: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 24 January 2020 regarding the exercise of employee share options and issue of 275,000 new shares in the Company. The NOK 71,500 share capital increase pertaining to the exercise of the employee share options…
Oslo, 25 February 2020 – Observe Medical ASA (OSE: OBSERV) continued implementation of its growth strategy in the fourth quarter of 2019, including the commercialization of its first product Sippi®. “In the fourth quarter of 2019, we have taken important steps in the commercialization of Sippi. In parallel we have strengthened our foundation for value…
Observe Medical ASA invites you to a presentation of the fourth quarter and full year 2019 figures. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, February 25th.
(Oslo, 24 January 2020) Exercise of employee share options In connection with the expiry date at 24 January three employees in Navamedic ASA have exercised a total of 275,000 options in Observe Medical ASA. Employees in Navamedic ASA were granted options in Observe Medical ASA in connection with the demerger of Navamedic ASA’s Medtech division… Observe Medical ASA: Interim report fourth quarter 2020
Observe Medical – Nya Karolinska Sjukhuset in Sweden resumes the implementation of Sippi® in clinical use at Cardiothoracic ICU unit
Observe Medical ASA : Invitation to fourth quarter 2020 presentation
Observe Medical – Sippi® installed in clinical use at ICU department at major hospital in Northern Italy
Observe Medical ASA – Strengthened presence in Norway through collaborations with Yallow Life Science AS and Norway Health Tech
Observe Medical receives significant order for medical consumables from a hospital region in the Nordic market
Observe Medical ASA – Doctoral dissertation further demonstrates clinical benefits of Sippi®
Observe Medical ASA – Enhanced Nordic sales team in full operations, driving Sippi® clinical use in the Nordics, following the recent acquisition of Sylak AB
Observe Medical ASA: Interim report third quarter 2020
Observe Medical ASA : Invitation to third quarter 2020 presentation
Observe Medical ASA – Closing of the transaction to acquire Sylak AB completed.
Observe Medical ASA – Final agreement to acquire Sylak AB signed
Observe Medical ASA – Signs agreement with the intention to acquire Sylak AB
Observe Medical ASA: Registration of share capital increase following exercise of employee share options
Observe Medical ASA: Exercise of share options, resolution to increase the share capital and mandatory notification of trade
Observe Medical ASA: Interim report second quarter and first half year 2020
Observe Medical: Scientific article provides evidence of Sippi® technology reducing microbial biofilm formation – a risk factor for patient infection
Observe Medical ASA : Invitation to second quarter and first half year of 2020 presentation
Observe Medical signs updated distribution agreement for Sippi® in Italy
Observe Medical ASA: Mandatory notification of trades by primary insider
Observe Medical ASA – Registration of share capital increase
Observe Medical ASA – Primary insider notice
Observe Medical ASA – Major shareholding notification and primary insider notice
Observe Medical ASA – Final result of the Rights Issue
Observe Medical ASA – Preliminary results of the Rights Issue
Observe Medical ASA: Primary Insider notification
Observe Medical ASA – The subscription period for the rights issue expires today
Observe Medical ASA – Last day of trading in subscription rights
Observe Medical ASA – Primary insider notice
Observe Medical ASA: Annual General Meeting held
Observe Medical ASA – Primary insider notice
Observe Medical ASA – Primary insider notice
Observe Medical ASA – Investor presentations in connection with the rights issue
Observe Medical ASA – Commencement of the subscription period for the rights issue
Observe Medical ASA – Approval and publication of the prospectus for the rights issue
Observe Medical ASA – Rights issue approved by the extraordinary general meeting
Observe Medical ASA – Correction: Terms of the underwritten rights issue
Updated key information relating to the preferential rights issue
Observe Medical ASA – Terms of the underwritten rights issue
Observe Medical ASA: Notice of Annual General Meeting
OBSERVE MEDICAL ASA: KEY INFORMATION RELATING TO THE PREFERENTIAL RIGHTS ISSUE
OBSERVE MEDICAL ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING – FULLY UNDERWRITTEN RIGHTS ISSUE
Observe Medical ASA: Q1 2020 financial results
Observe Medical ASA : Invitation to first quarter 2020 presentation
Observe Medical ASA: Annual report for 2019
Observe Medical ASA: Business update in light of COVID-19
Observe Medical ASA – Registration of share capital increase following exercise of employee share options
Observe Medical ASA: Q4 2019 financial results
Observe Medical ASA: Invitation to fourth quarter and full year 2019 presentation
Observe Medical ASA: Exercise of employee share options and increased share capital